EDITORIAL
Published on 16 Aug 2022
Editorial: Drug resistance in lung cancer chemotherapy and personalized chemotherapy
doi 10.3389/fcell.2022.971477
- 1,079 views
- 1 citation
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Drug Resistance in Lung Cancer Chemotherapy and Personalized Chemotherapy
Drug Resistance in Lung Cancer Chemotherapy and Personalized Chemotherapy
7,557
Total downloads
21k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 25 Mar 2022
Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
doi 10.3389/fonc.2022.851276
- 2,133 views
- 3 citations
ORIGINAL RESEARCH
Published on 02 Mar 2022
Mechanisms of Senescence-Related NKG2D Ligands Release and Immune Escape Induced by Chemotherapy in Neuroblastoma Cells
doi 10.3389/fcell.2022.829404
- 2,616 views
- 14 citations
ORIGINAL RESEARCH
Published on 11 Jan 2022
CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
doi 10.3389/fcell.2021.770811
- 2,423 views
- 5 citations
CASE REPORT
Published on 07 Jan 2022
Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous Histology
doi 10.3389/fonc.2021.788245
- 2,553 views
- 4 citations
ORIGINAL RESEARCH
Published on 23 Dec 2021
Deciphering the Mechanism of Gilteritinib Overcoming Lorlatinib Resistance to the Double Mutant I1171N/F1174I in Anaplastic Lymphoma Kinase
doi 10.3389/fcell.2021.808864
- 2,644 views
- 15 citations
ORIGINAL RESEARCH
Published on 08 Dec 2021
Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
doi 10.3389/fcell.2021.769881
- 1,735 views
- 5 citations
ORIGINAL RESEARCH
Published on 29 Oct 2021
Efficacy and Safety of Drug-Eluting Bead Bronchial Arterial Chemoembolization Plus Anlotinib in Patients With Advanced Non-small-Cell Lung Cancer
doi 10.3389/fcell.2021.768943
- 1,554 views
- 11 citations
Published in
Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Molecular and Cellular OncologyOffline
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 21kTopic views
- 12kArticle views
- 7,557Article downloads